UPDATE ON OBESITY AND CARDIOVASCULAR RISK: FROM PATHOPHYSIOLOGY TO CLINICAL MANAGEMENT

Descargar Publicación
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study